LigaChem Biosciences Inc. (KOSDAQ:141080)

South Korea flag South Korea · Delayed Price · Currency is KRW
177,200
+1,700 (0.97%)
Nov 17, 2025, 3:30 PM KST
0.97%
Market Cap6.39T
Revenue (ttm)148.28B
Net Income (ttm)1.75B
Shares Out36.41M
EPS (ttm)47.94
PE Ratio3,648.17
Forward PE122.84
Dividendn/a
Ex-Dividend Daten/a
Volume637,840
Average Volume566,588
Open172,800
Previous Close175,500
Day's Range169,400 - 180,900
52-Week Range89,500 - 178,600
Beta0.81
RSI68.93
Earnings DateNov 14, 2025

About LigaChem Biosciences

LigaChem Biosciences Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of medicines for unmet medical needs. The company researches and develops products for various therapeutic areas, including antibiotics, anti-fibrotics, immuno-oncology, oncology; and antibody-drug conjugate (ADC) platform technology and small molecule drugs. It also sells medical device and supplies. It has a research collaboration and license agreement with AMGEN for the development and commercialization of ADCs. The company was for... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2006
Employees 170
Stock Exchange KOSDAQ
Ticker Symbol 141080
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.